Clinical Trials Directory

Trials / Sponsors / Corbus Pharmaceuticals Inc.

Corbus Pharmaceuticals Inc.

Industry · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants
Obese But Otherwise Healthy Participants
Phase 12025-12-04
RecruitingFirst-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Solid Tumor
Phase 1 / Phase 22024-12-04
RecruitingA Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Solid Tumor, Adult
Phase 1 / Phase 22024-04-01
CompletedTrial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Dermatomyositis
Phase 32018-12-17
CompletedTrial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Cystic Fibrosis
Phase 22017-12-22
TerminatedTrial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 32017-12-18
CompletedSafety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
Cystic Fibrosis
Phase 22015-09-29
TerminatedSafety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 22015-08-01
TerminatedSafety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Dermatomyositis
Phase 22015-06-01